NCT02884128 A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02817113 Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer Status TERMINATED Phase PHASE1
NCT02785068 Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02778191 Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase N/A
NCT02715531 A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors Status COMPLETED Phase PHASE1
NCT02710734 Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) Status COMPLETED Phase PHASE2
NCT02641873 A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT02550678 A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02494583 Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) Status COMPLETED Phase PHASE3
NCT02485834 FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer Status TERMINATED Phase PHASE2
NCT02453464 A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE1
NCT02384850 Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1
NCT02358031 A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) Status COMPLETED Phase PHASE3
NCT02335411 A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059) Status COMPLETED Phase PHASE2
NCT02287129 Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT02280070 RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). Status UNKNOWN Phase PHASE2
NCT02229045 Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT02218164 Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT02143219 Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2